| Amgen (AMGN) |
United States |
$148.915B |
16.40 |
| Bristol Myers Squibb (BMY) |
United States |
$136.418B |
11.40 |
| Gilead Sciences (GILD) |
United States |
$95.859B |
12.43 |
| CSL (CSLLY) |
Australia |
$91.400B |
0.00 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$77.539B |
53.31 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$70.508B |
27.18 |
| Illumina (ILMN) |
United States |
$54.702B |
56.21 |
| Biogen (BIIB) |
United States |
$43.791B |
7.50 |
| Seattle Genetics (SGEN) |
United States |
$30.490B |
0.00 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$24.834B |
10.67 |
| Incyte (INCY) |
United States |
$23.618B |
0.00 |
| SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$23.288B |
0.00 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$23.144B |
209.80 |
| Moderna (MRNA) |
United States |
$22.678B |
0.00 |
| Genmab (GMAB) |
Denmark |
$22.443B |
18.48 |
| Genmab (GNMSF) |
Denmark |
$21.119B |
62.70 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$18.457B |
0.00 |
| BioNTech SE (BNTX) |
Germany |
$15.689B |
0.00 |
| BeiGene (BGNE) |
Cayman Islands |
$15.289B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$13.179B |
38.77 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$12.955B |
58.97 |
| Exact Sciences (EXAS) |
United States |
$12.938B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$12.782B |
0.00 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$11.536B |
0.00 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$10.930B |
26.90 |
| Bio-Techne Corp (TECH) |
United States |
$10.196B |
67.36 |
| QIAGEN (QGEN) |
Netherlands |
$9.837B |
28.60 |
| Immunomedics (IMMU) |
United States |
$9.504B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$8.884B |
0.00 |
| Guardant Health (GH) |
United States |
$8.066B |
0.00 |
| Exelixis (EXEL) |
United States |
$7.167B |
25.13 |
| Ascendis Pharma (ASND) |
Denmark |
$7.083B |
0.00 |
| Repligen (RGEN) |
United States |
$6.493B |
113.89 |
| Novavax (NVAX) |
United States |
$6.060B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
United States |
$5.907B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$5.664B |
121.88 |
| Acceleron Pharma (XLRN) |
United States |
$5.535B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$5.242B |
0.00 |
| Vir Biotechnology (VIR) |
United States |
$5.229B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$5.173B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$5.123B |
0.00 |
| Zai Lab (ZLAB) |
China |
$4.812B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$4.691B |
30.75 |
| MyoKardia (MYOK) |
United States |
$4.390B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$4.341B |
33.67 |
| China Biologic Products (CBPO) |
China |
$4.210B |
23.40 |
| Blueprint Medicines (BPMC) |
United States |
$4.183B |
0.00 |
| Amicus Therapeutics (FOLD) |
United States |
$4.094B |
0.00 |
| Global Blood Therapeutics (GBT) |
United States |
$4.077B |
0.00 |
| Momenta Pharmaceuticals (MNTA) |
United States |
$3.974B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$3.809B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$3.774B |
0.00 |
| NeoGenomics (NEO) |
United States |
$3.727B |
272.15 |
| Bluebird Bio (BLUE) |
United States |
$3.577B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$3.212B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$3.189B |
62.78 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$3.067B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$2.915B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$2.813B |
0.00 |
| Insmed (INSM) |
United States |
$2.794B |
0.00 |
| Amarin (AMRN) |
Ireland |
$2.598B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$2.479B |
0.00 |
| Viela Bio (VIE) |
United States |
$2.157B |
0.00 |
| UniQure (QURE) |
Netherlands |
$2.027B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$2.000B |
0.00 |
| Eidos Therapeutics (EIDX) |
United States |
$1.917B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$1.903B |
0.00 |
| Principia Biopharma (PRNB) |
United States |
$1.877B |
0.00 |
| Alector (ALEC) |
United States |
$1.858B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$1.777B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$1.762B |
68.62 |
| Zymeworks (ZYME) |
Canada |
$1.759B |
0.00 |
| Forma Therapeutics Holdings (FMTX) |
United States |
$1.708B |
0.00 |
| I-Mab (IMAB) |
China |
$1.680B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$1.644B |
0.00 |
| Epizyme (EPZM) |
United States |
$1.630B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$1.614B |
0.00 |
| Cytokineticsorporated (CYTK) |
United States |
$1.549B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$1.548B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$1.495B |
0.00 |
| Mesoblast (MESO) |
Australia |
$1.484B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.482B |
0.00 |
| Beam Therapeutics (BEAM) |
United States |
$1.473B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$1.464B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$1.459B |
0.00 |
| Akcea Therapeutics (AKCA) |
United States |
$1.420B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.404B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$1.369B |
0.00 |
| NGM Biopharmaceuticals (NGM) |
United States |
$1.361B |
0.00 |
| Arvinas (ARVN) |
United States |
$1.307B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.269B |
8.86 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$1.259B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$1.235B |
0.00 |
| NantKwest (NK) |
United States |
$1.208B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$1.166B |
0.00 |
| Athenex (ATNX) |
United States |
$1.086B |
0.00 |
| Compugen (CGEN) |
Israel |
$1.082B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$1.000B |
0.00 |
| Alcobra (ARCT) |
United States |
$0.988B |
0.00 |
| Retrophin (RTRX) |
United States |
$0.902B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$0.862B |
44.46 |
| Heska (HSKA) |
United States |
$0.852B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$0.834B |
35.83 |
| Pharming Group (PHGUF) |
Netherlands |
$0.826B |
22.00 |
| Cara Therapeutics (CARA) |
United States |
$0.819B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$0.813B |
0.00 |
| Morphic Holding (MORF) |
United States |
$0.776B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.775B |
0.00 |
| Intrexon (PGEN) |
United States |
$0.775B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.757B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.738B |
0.00 |
| Codexis (CDXS) |
United States |
$0.727B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$0.704B |
0.00 |
| Frequency Therapeutics (FREQ) |
United States |
$0.696B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.693B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.689B |
0.00 |
| Agenus (AGEN) |
United States |
$0.670B |
0.00 |
| Vericel (VCEL) |
United States |
$0.662B |
122.33 |
| Cue Biopharma (CUE) |
United States |
$0.646B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.640B |
20.87 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.629B |
5.39 |
| AnaptysBio (ANAB) |
United States |
$0.618B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.605B |
0.00 |
| MiMedx (MDXG) |
United States |
$0.597B |
0.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.583B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.557B |
0.00 |
| Aquinox Pharmaceuticals (NLTX) |
United States |
$0.557B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.545B |
0.00 |
| Athersys (ATHX) |
United States |
$0.540B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.529B |
0.00 |
| Cel-Sci (CVM) |
United States |
$0.519B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.512B |
16.48 |
| NextCure (NXTC) |
United States |
$0.512B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$0.509B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.509B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$0.508B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.506B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.503B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.502B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.492B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.467B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.450B |
0.00 |
| Geron (GERN) |
United States |
$0.445B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.443B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.437B |
22.95 |
| Precision BioSciences (DTIL) |
United States |
$0.429B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.427B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.426B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.409B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.406B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.390B |
0.00 |
| MannKind (MNKD) |
United States |
$0.386B |
0.00 |
| Albireo Pharma (ALBO) |
United States |
$0.383B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.378B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.371B |
7.35 |
| Kamada (KMDA) |
Israel |
$0.369B |
15.33 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.344B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.335B |
287.50 |
| Affimed (AFMD) |
Germany |
$0.335B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.330B |
0.00 |
| Cellular Biomedicine (CBMG) |
United States |
$0.318B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.313B |
0.00 |
| Prometic Life Sciences (LMNL) |
Canada |
$0.309B |
0.00 |
| Menlo Therapeutics (MNLO) |
United States |
$0.290B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.285B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$0.284B |
0.00 |
| Pfenex (PFNX) |
United States |
$0.283B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.282B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.280B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.278B |
0.00 |
| AMAG Pharmaceuticals (AMAG) |
United States |
$0.270B |
0.00 |
| IBio (IBIO) |
United States |
$0.266B |
0.00 |
| IVERIC Bio (ISEE) |
United States |
$0.256B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.254B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$0.254B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.248B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.244B |
0.00 |
| Verastem (VSTM) |
United States |
$0.244B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.241B |
0.00 |
| Gritstone Oncology (GRTS) |
United States |
$0.236B |
0.00 |
| HOOKIPA Pharma (HOOK) |
United States |
$0.234B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.231B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.228B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.223B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.223B |
0.00 |
| XOMA (XOMA) |
United States |
$0.220B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.218B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.216B |
0.00 |
| Aduro Biotech (ADRO) |
United States |
$0.212B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.211B |
0.00 |
| Exicure (XCUR) |
United States |
$0.207B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.207B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.203B |
3.06 |
| Bellus Health (BLU) |
Canada |
$0.200B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.195B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.194B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.193B |
0.00 |
| Trevena (TRVN) |
United States |
$0.175B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.174B |
0.00 |
| Aytu Bioscience (AYTU) |
United States |
$0.162B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.159B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.157B |
0.00 |
| Cerecor (CERC) |
United States |
$0.156B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.152B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.151B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.149B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.149B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.145B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.145B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.141B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.139B |
0.00 |
| VolitionRX (VNRX) |
United States |
$0.138B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.136B |
0.00 |
| Lumos Pharma (LUMO) |
United States |
$0.132B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.131B |
0.00 |
| Arbutus Biopharma (ABUS) |
United States |
$0.128B |
0.00 |
| Lineage Cell Therapeutics (LCTX) |
United States |
$0.123B |
0.00 |
| Celsion (CLSN) |
United States |
$0.121B |
0.00 |
| Catabasis Pharmaceuticals (CATB) |
United States |
$0.121B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.120B |
0.00 |
| Palatin Technologies (PTN) |
United States |
$0.119B |
3.05 |
| Enzo Biochem (ENZ) |
United States |
$0.119B |
0.00 |
| Protalix BioTherapeutics (PLX) |
Israel |
$0.117B |
0.00 |
| AIT Therapeutics (XAIR) |
United States |
$0.116B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.112B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.104B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.097B |
0.00 |
| Cardiff Oncology (CRDF) |
United States |
$0.097B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.096B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.095B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.092B |
0.00 |
| Emmaus Life Sciences (EMMA) |
United States |
$0.089B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$0.087B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.085B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.083B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.083B |
0.00 |
| Adocia (ADOCY) |
France |
$0.080B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.078B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.078B |
0.00 |
| Unum Therapeutics (UMRX) |
United States |
$0.074B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.072B |
0.00 |
| Proteostasis Therapeutics (PTI) |
United States |
$0.071B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.070B |
0.00 |
| Happiness Biotech Group (HAPP) |
China |
$0.069B |
0.00 |
| AnPac Bio-Medical Science (ANPC) |
China |
$0.069B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.068B |
0.00 |
| Stealth BioTherapeutics (MITO) |
United States |
$0.065B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.062B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.061B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.059B |
0.00 |
| Ecology Coatings (ABVC) |
United States |
$0.058B |
0.00 |
| Aridis Pharmaceuticals (ARDS) |
United States |
$0.057B |
0.00 |
| Signal Genetics (MGEN) |
United States |
$0.056B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.054B |
0.00 |
| CollPlant Holdings (CLGN) |
Israel |
$0.054B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.053B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.052B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.047B |
0.00 |
| Apricus Biosciences (SEEL) |
United States |
$0.046B |
0.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.044B |
0.00 |
| AmpliPhi Biosciences (ARMP) |
United States |
$0.044B |
0.00 |
| Curis (CRIS) |
United States |
$0.043B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.041B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$0.040B |
0.00 |
| ATyr Pharma (LIFE) |
United States |
$0.040B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.034B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.034B |
0.00 |
| Cesca Therapeutics (THMO) |
United States |
$0.034B |
0.00 |
| Chanticleer Holdings (SONN) |
United States |
$0.032B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.031B |
0.00 |
| OvaScience (MLND) |
United States |
$0.031B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.030B |
0.00 |
| Spherix (AIKI) |
United States |
$0.030B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.029B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.029B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.028B |
0.00 |
| BioPharmX (TMBR) |
United States |
$0.027B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.027B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.026B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.026B |
0.00 |
| PLANET GREEN HOLDINGS CORP (PLAG) |
China |
$0.025B |
0.00 |
| FORTE BIOSCIENC (FBRX) |
United States |
$0.024B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.022B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.022B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.021B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.020B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.016B |
0.00 |
| MYOS RENS Technology (MYOS) |
United States |
$0.016B |
0.00 |
| VIVUS (VVUS) |
United States |
$0.014B |
0.00 |
| Neuralstem (SNCA) |
United States |
$0.014B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.012B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.010B |
0.00 |
| Benitec Biopharma (BNTC) |
Australia |
$0.007B |
0.00 |
| Innate Pharma S.A (IPHA) |
France |
$0.000B |
0.00 |
